CSL305: A Dual Functional Therapeutic Antibody Targeting Complement C2 and FcRn.

Wymann S, Morales RAV, Toh WH, Remlinger J, Guse K, Ghai R, Pestel S, Sansome G, Chen CG, Rayzman V, Chia J, Quek AJ, Gorman MA, Halder P, Powers G, Ruthsatz T, Parker MW, Rowe T, Vyas S, Verhagen AM, Hardy MP

Open source

DOI: 10.3390/ijms27052383
Published: 2026 Mar 4
Container: International journal of molecular sciences
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/ijms27052383,
  title = {CSL305: A Dual Functional Therapeutic Antibody Targeting Complement C2 and FcRn.},
  author = {Wymann S and Morales RAV and Toh WH and Remlinger J and Guse K and Ghai R and Pestel S and Sansome G and Chen CG and Rayzman V and Chia J and Quek AJ and Gorman MA and Halder P and Powers G and Ruthsatz T and Parker MW and Rowe T and Vyas S and Verhagen AM and Hardy MP},
  year = {2026},
  journal = {International journal of molecular sciences},
  doi = {10.3390/ijms27052383},
  url = {https://doi.org/10.3390/ijms27052383}
}

RIS

TY  - JOUR
TI  - CSL305: A Dual Functional Therapeutic Antibody Targeting Complement C2 and FcRn.
AU  - Wymann S
AU  - Morales RAV
AU  - Toh WH
AU  - Remlinger J
AU  - Guse K
AU  - Ghai R
AU  - Pestel S
AU  - Sansome G
AU  - Chen CG
AU  - Rayzman V
AU  - Chia J
AU  - Quek AJ
AU  - Gorman MA
AU  - Halder P
AU  - Powers G
AU  - Ruthsatz T
AU  - Parker MW
AU  - Rowe T
AU  - Vyas S
AU  - Verhagen AM
AU  - Hardy MP
PY  - 2026
JO  - International journal of molecular sciences
DO  - 10.3390/ijms27052383
UR  - https://doi.org/10.3390/ijms27052383
ER  -

APA

S, W., RAV, M., WH, T., J, R., K, G., R, G., S, P., G, S., CG, C., V, R., J, C., AJ, Q., MA, G., P, H., G, P., T, R., MW, P., T, R., S, V., AM, V., & MP, H. (2026). CSL305: A Dual Functional Therapeutic Antibody Targeting Complement C2 and FcRn.. International journal of molecular sciences. https://doi.org/10.3390/ijms27052383

Source records

pubmed · retrieved 2026-09-25T10:19:42.057Z